Log in to your Inderes Free account to see all free content on this page.
Novonesis
405.3
DKK
+1.68 %
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
21 following
+1.68%
-1.98%
-10.29%
-8.37%
-6.91%
+9.22%
+12.58%
-21.02%
+29.74%
+995.41%
investors.novozymes.com/investors/default.aspx
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Revenue
17.9B
EBIT %
22.21 %
P/E
37.12
Dividend yield-%
1.53 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
NSIS B
Daily low / high price
400.1 / 407.3
DKK
Market cap
189.8B DKK
Turnover
287.42M DKK
Volume
710K
Financial calendar
Annual report
26.02.2025
General meeting
03.04.2025
Interim report
13.08.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Novo Holdings A/S | 25.5 % | 72.4 % |
ShowingAll content types
Novonesis will host an educational conference call on Energy on December 18
Major shareholder announcement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio